Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood

dc.contributor.authorRaitakari Olli
dc.contributor.authorKartiosuo Noora
dc.contributor.authorPahkala Katja
dc.contributor.authorHutri-Kähönen Nina
dc.contributor.authorBazzano Lydia A
dc.contributor.authorChen Wei
dc.contributor.authorUrbina Elaine M
dc.contributor.authorJacobs David R
dc.contributor.authorSinaiko Alan
dc.contributor.authorSteinberger Julia
dc.contributor.authorBurns Trudy
dc.contributor.authorDaniels Stephen R
dc.contributor.authorVenn Alison
dc.contributor.authorWoo Jessica G
dc.contributor.authorDwyer Terry
dc.contributor.authorJuonala Markus
dc.contributor.authorViikari Jorma
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=sydäntutkimuskeskus|en=Cardiovascular Medicine (CAPC)|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)|
dc.contributor.organization-code1.2.246.10.2458963.20.35734063924
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.42471027641
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code2607008
dc.converis.publication-id177793241
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/177793241
dc.date.accessioned2025-08-28T02:52:03Z
dc.date.available2025-08-28T02:52:03Z
dc.description.abstract<p><strong>Background: </strong>Elevated lipoprotein(a) [Lp(a)] is a common risk factor for cardiovascular disease outcomes with unknown mechanisms. We examined its potential role in identifying youths who are at increased risk of developing adult atherosclerotic cardiovascular disease (ASCVD).</p><p><strong>Methods: </strong>Lp(a) levels measured in youth 9 to 24 years of age were linked to adult ASCVD and carotid intima-media thickness in the YFS (Cardiovascular Risk in Young Finns Study), in which 95 of the original 3596 participants (2.7%) recruited as children have been diagnosed with ASCVD at a median of 47 years of age. Results observed in YFS were replicated with the use of data for White participants from the BHS (Bogalusa Heart Study). In BHS, 587 White individuals had data on youth Lp(a) (measured at 8-17 years of age) and information on adult events, including 15 cases and 572 noncases. Analyses were performed with the use of Cox proportional hazard regression.</p><p><strong>Results: </strong>In YFS, those who had been exposed to high Lp(a) level in youth [defined as Lp(a) ≥30 mg/dL] had ≈2 times greater risk of developing adult ASCVD compared with nonexposed individuals (hazard ratio, 2.0 [95% CI, 1.4-2.6]). Youth risk factors, including Lp(a), low-density lipoprotein cholesterol, body mass index, and smoking, were all independently associated with higher risk. In BHS, in an age- and sex-adjusted model, White individuals who had been exposed to high Lp(a) had 2.5 times greater risk (95% CI, 0.9-6.8) of developing adult ASCVD compared with nonexposed individuals. When also adjusted for low-density lipoprotein cholesterol and body mass index, the risk associated with high Lp(a) remained unchanged (hazard ratio, 2.4 [95% CI, 0.8-7.3]). In a multivariable model for pooled data, individuals exposed to high Lp(a) had 2.0 times greater risk (95% CI, 1.0-3.7) of developing adult ASCVD compared with nonexposed individuals. No association was detected between youth Lp(a) and adult carotid artery thickness in either cohort or pooled data.</p><p><strong>Conclusions: </strong>Elevated Lp(a) level identified in youth is a risk factor for adult atherosclerotic cardiovascular outcomes but not for increased carotid intima-media thickness.</p>
dc.format.pagerange23
dc.format.pagerange31
dc.identifier.eissn1524-4539
dc.identifier.jour-issn0009-7322
dc.identifier.olddbid209847
dc.identifier.oldhandle10024/192874
dc.identifier.urihttps://www.utupub.fi/handle/11111/49669
dc.identifier.urlhttps://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.060667
dc.identifier.urnURN:NBN:fi-fe202301132748
dc.language.isoen
dc.okm.affiliatedauthorRaitakari, Olli
dc.okm.affiliatedauthorKartiosuo, Noora
dc.okm.affiliatedauthorPahkala, Katja
dc.okm.affiliatedauthorJuonala, Markus
dc.okm.affiliatedauthorViikari, Jorma
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherAmerican Heart Association
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1161/CIRCULATIONAHA.122.060667
dc.relation.ispartofjournalCirculation
dc.relation.issue1
dc.relation.volume147
dc.source.identifierhttps://www.utupub.fi/handle/10024/192874
dc.titleLipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Lipoprotein(a) in youth.pdf
Size:
290.49 KB
Format:
Adobe Portable Document Format